Premium
Genetic variation of E6 and E7 genes of human papillomavirus 52 from Central China
Author(s) -
Li Shuo,
Ye Mengxia,
Chen Yonglin,
Gong Quan,
Mei Bing
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26690
Subject(s) - nonsynonymous substitution , phylogenetic tree , biology , genetics , gene , synonymous substitution , epitope , genetic variation , virology , genome , codon usage bias , antibody
Cervical cancer is the fourth most common malignant tumor in women worldwide and is closely related to human papillomavirus (HPV). Women have the highest susceptibility to HPV‐52 type in Jingzhou, China. In this study, E6‐E7 sequences of 183 HPV‐52 positive samples were amplified by a polymerase chain reaction and sequenced. HPV‐52 E6‐E7 gene variations were analyzed. The phylogenetic tree was constructed using the Kimura 2‐parameter method. The secondary structure of the protein was analyzed. The selective pressure to E6‐E7 genes was estimated using PAML. In addition, the B cell epitopes of the E6‐E7 sequences in HPV‐52 were predicted by the ABCpred server. In E6 sequences, 15 single nucleotide variants were observed, including 6 nonsynonymous variants and 9 synonymous variants. In E7 sequences, 19 single nucleotide variants occurred, including 10 nonsynonymous variants and 9 synonymous variants. Six amino acid variants, including 3 nonconservative substitutions, were found in sequences encoding the alpha helix. Eight amino acid variants, including three nonconservative substitutions, occurred in sequences encoding the strand. Through phylogenetic analysis, the E6‐E7 sequences were mainly distributed in B lineage. In HPV‐52 E6‐E7 sequences, no positively selected site was found. The nonconservative substitutions, such as K93R, K93E in E6, T37I, and D38N in E7, affected multiple hypothetical epitopes in the B cell. This study provides information for the investigation of HPV epidemic characters. The discovery of new variants of HPV‐52 may lay the basis for the development of the virus diagnosis, further study of cervical cancer, and vaccine design in Central China.